Direct oral anticoagulants: An update
Ana Isabel Franco Moreno1, Rosa María Martín Díaz1, María José García Navarro1
1Servicio de Medicina Interna, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, España.
Direct oral anticoagulants (DOACs) offer a favorable safety and efficacy profile for preventing thromboembolic events. These newer anticoagulants are effective alternatives to traditional vitamin K antagonists for various cardiovascular conditions.
Area of Science:
- Pharmacology and Therapeutics
- Cardiovascular Medicine
- Hematology
Background:
- Vitamin K antagonists (VKAs) were the sole oral anticoagulation therapy for over 50 years.
- Direct oral anticoagulants (DOACs) have recently emerged as alternatives.
- DOACs include direct thrombin inhibitors and factor Xa inhibitors.
Purpose of the Study:
- To review the evidence supporting the use of direct oral anticoagulants.
- To compare the safety and efficacy of DOACs versus VKAs.
Main Methods:
- Review of randomized controlled trials comparing DOACs with VKAs.
- Analysis of data on thromboembolic event prevention and treatment.
Main Results:
- DOACs demonstrated a favorable benefit-risk balance compared to VKAs.
- Efficacy in preventing thromboembolic events in atrial fibrillation.
- Effectiveness in venous thromboembolism and acute coronary syndrome management.
Conclusions:
- DOACs represent a significant advancement in oral anticoagulation.
- Dabigatran, rivaroxaban, apixaban, and edoxaban are approved DOACs.
- These agents offer a favorable safety and efficacy profile for key indications.
More Related Videos
08:22Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
10:11Updated Technique for Reliable, Easy, and Tolerated Transcranial Electrical Stimulation Including Transcranial Direct Current Stimulation
Published on: January 3, 2020
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Oral Cavity
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
Directing Effect of Substituents: meta-Directing Groups
Oral Hypoglycemic Agents: Glinides
Psychosexual Stages of Personality: Oral
Weaning, typically occurring...
